Medtech companies directory 2026

    Medical Device Companies in Italy

    Italian hospital technology is a regional-tender market with a Roman overlay: the Ministry of Health holds the device register, AIFA’s shadow still appears on some reimbursement conversations, and the real envelope is opened by a regione — Lombardia, Lazio, Emilia-Romagna, Veneto — or by Consip when the lot is national enough.

    LivaNova (the Sorin heritage), Diasorin, Menarini Diagnostics, Esaote and Artsana are the Italian houses a ospedale universitario biomedical engineer already knows — cardiac surgery, IVD, ultrasound, baby and consumer-adjacent medical. Siemens, GE, Philips and Medtronic keep Milano and Roma seats that bid regional gare and still appoint distributori for the Mezzogiorno. The Ministry’s medical-device directorate is the register; regional centrali di committenza and ASL/AO purchasing are the volume. BioNixus fields named regioni, not a single “Italian hospital” average.

    Updated September 2026 · Ministero della Salute — medical devices directorate and national register as of September 2026 · 16 named accounts

    Request a proposal for ItalyBrowse the 16 companies

    Ministry

    Ministero della Salute device register and national overlay

    Regioni

    Regional centrali di committenza that actually open the envelope

    Consip

    National framework path used when a lot is wide enough to leave the regione

    CHU-peers

    IRCCS and university hospitals whose specs a provincial ASL will not copy

    Named accounts

    Top medical device companies in Italy

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Ministero della Salute — medical devices directorate and national register (as of 2026-09-05).
    #CompanyHQ
    01Ministry of Health — medical devices directorateRome
    02Regional centrali di committenza (ARIA, Intercent-ER and peers)Milan / Bologna / regional capitals
    03LivaNova (Sorin heritage)London / Mirandola heritage
    04DiasorinSaluggia
    05Menarini DiagnosticsFlorence
    06EsaoteGenoa
    07Artsana (medical-adjacent)Grandate
    08Siemens Healthineers ItaliaMilan
    09GE HealthCare ItaliaMilan
    10Medtronic ItaliaMilan
    11Consip (national conventions)Rome
    12Italian hospital distributoriMilan / Rome / regional
    13Humanitas / San Donato / GVM — private-group purchasingMilan / regional
    14Philips Italia (Health Systems)Milan
    15IRCCS and university-hospital provveditoratiMilan / Rome / Turin / Bologna
    16Johnson & Johnson MedTech ItaliaRome / Milan

    Primary research

    These are the medical device companies accounts we study in Italy

    Need account-level or SKU-level data for a brand in Italy? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

    Planning research in Italy?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top healthcare market research companies in Italy (2026)

    How the market is structured

    Ministry register, regional gara, distributore invoice

    A device that will be used in an Italian public hospital needs a Ministry of Health registration (and an EU MDR certificate), plus a place on a regional gara, an ASL/AO lot or a Consip convention that the ospedale’s provveditorato will raise against. That is a different object from a CE mark a Swiss hub waves at a Milano biomedical engineer. Capital equipment is specified by the unità operativa and purchased by the regione’s centrale or by the individual IRCCS when the statute allows. Lombardia’s ARIA, Lazio’s regional vehicles, Intercent-ER in Emilia-Romagna and their peers do not share one catalogue. Consumables, implants and IVD reagents ride distributori who hold inventory in Italian magazzini and appear on the ospedale’s anagrafica fornitori. LivaNova’s cardiac-surgery heritage still sits in Italian sale operatorie; Diasorin’s immunoassay placements lock reagents into hospital and private labs; Menarini Diagnostics defends a point-of-care and lab book; Esaote competes in ultrasound and dedicated MRI inside the same rooms GE and Philips treat as theirs; Artsana’s medical-adjacent baby and consumer book should be labelled honestly and not filed as a cath-lab peer. AIFA does not run the device register the way it runs drugs, but reimbursement conversations still drag its name into the room — BioNixus keeps the Ministry file and the AIFA shadow in separate folders. Private gruppi (Humanitas, San Donato, GVM) buy on committee cycles. BioNixus reconstructs the named Ministry number, the named regional gara and the named provveditorato before an Italy volume figure is signed.

    Local

    Italian cardiac, IVD, ultrasound and medical-adjacent houses — LivaNova heritage, Diasorin, Menarini Diagnostics, Esaote, Artsana labelled honestly.

    • LivaNova (Sorin heritage)
    • Diasorin
    • Menarini Diagnostics
    • Esaote
    • Artsana (medical-adjacent)

    Multinational

    Milano and Roma multinational seats that win IRCCS rooms and still share provincial invoices with distributori.

    • Siemens Healthineers Italia
    • GE HealthCare Italia
    • Medtronic Italia
    • Philips Italia (Health Systems)
    • Johnson & Johnson MedTech Italia

    Regional

    Distributori and Mezzogiorno-facing houses that hold the anagrafica fornitori number outside the northern IRCCS.

    Distributors & service partners

    Ministry register in Rome, regional centrali and Consip as the lots, ASL/AO provveditorati as the dock.

    • Ministry of Health — medical devices directorate
    • Regional centrali di committenza (ARIA, Intercent-ER and peers)
    • Consip (national conventions)
    • Italian hospital distributori
    • Humanitas / San Donato / GVM — private-group purchasing
    • IRCCS and university-hospital provveditorati

    What is moving

    What is moving the medical device market in Italy

    Regional gara fragmentation

    Lombardia, Lazio, Emilia-Romagna and a Sicilian ASL open on different statutes. A Milano award that never reached Palermo is a failed national launch.

    Ministry register versus AIFA shadow

    The device file sits at the Ministry. Reimbursement talk still drags AIFA into the room. BioNixus keeps those two folders apart.

    IRCCS specs versus provincial ASL lots

    Humanitas, Policlinico and peer IRCCS write academic specs a district ospedale will not copy; a launch needs both samples.

    Private-group committee speed

    San Donato, GVM and Humanitas will trial a SKU the regional gara has not opened; mixing those clocks is the briefing error.

    BioNixus fieldwork

    How BioNixus studies medical device companies in Italy

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Italy:
    • Named regional gara reconstructions in Lombardia, Lazio, Emilia-Romagna and one southern ASL, treated as four buyers.
    • Ministry register-number traces against the carton a provveditorato accepts.
    • IRCCS versus provincial ASL specification interviews so a Policlinico spec is not copied onto a district lot.
    • Distributore coverage scores south of Rome so a Milano subsidiary is not counted as Mezzogiorno last-mile.

    Healthcare market research in Italy

    Questions

    Frequently Asked Questions

    Who regulates medical devices in Italy?

    The Ministry of Health holds the device register and the competent-authority overlay. EU MDR certificates come from notified bodies. AIFA may appear in reimbursement talk; it does not replace the Ministry file.

    Who buys devices for Italian public hospitals?

    Regional centrali di committenza open most gare. Consip is used for some national conventions. Individual ASL, AO and IRCCS provveditorati still run lots their statute allows.

    Which Italian manufacturers belong on a brief?

    LivaNova (Sorin heritage) for cardiac surgery, Diasorin and Menarini Diagnostics for IVD, Esaote for ultrasound and dedicated MRI, Artsana only where the medical-adjacent book is the brief.

    Does a Lombardia gara stock the whole country?

    No. Each regione is its own buyer. A northern award does not fill a southern ASL, and Consip is a third path, not a substitute for the centrale.

    What does BioNixus study on Italian device accounts?

    Ministry-number traces, named regional gara reconstructions, IRCCS versus ASL specification interviews, and distributore coverage scores south of Rome.

    Is this an Italian market-share ranking?

    No. Names appear because they recur in BioNixus ospedale and laboratorio fieldwork; sequence is by role, not by fatturato.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Italy. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Ministero della Salute — medical devices directorate and national register, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in Italy, not size.

    • Ministero della Salute medical-device register and notices, consulted 2026
    • Regional centrale and Consip gara notices (ARIA, Intercent-ER and peers)
    • LivaNova, Diasorin, Menarini Diagnostics, Esaote and Artsana published descriptions
    • BioNixus Italy IRCCS, ASL and regional-gara fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need device-level competitive data in Italy?

    Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

    Planning research in Italy?

    Primary research, market access & HEOR. Proposals within 48 hours.